Birchview Capital, LP Neurocrine Biosciences Inc Transaction History

Birchview Capital, LP

$108 Million
Q3 2024

A detailed history of Birchview Capital, LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Birchview Capital, LP holds 30,240 shares of NBIX stock, worth $4.1 Million. This represents 3.21% of its overall portfolio holdings.

Number of Shares

30,240

Previous 42,240 28.41%

Holding current value

$4.1 Million

Previous $5.82 Million 40.14%

% of portfolio

3.21%

Previous 5.81%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$114.58 - $153.15 $1.37 Million - $1.84 Million	-12,000 Reduced 28.41%	30,240 $3.48 Million
Q2 2024 Aug 13, 2024	SELL	$130.86 - $143.19 $4.58 Million - $5.01 Million	-35,000 Reduced 45.31%	42,240 $5.82 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $658,140 - $819,700	-7,000 Reduced 8.31%	77,240 $8.69 Million
Q4 2022 Feb 03, 2023	SELL	$106.72 - $127.06 $106,720 - $127,060	-1,000 Reduced 1.17%	84,240 $10.1 Million
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $303,160 - $400,280	-4,000 Reduced 4.48%	85,240 $8.31 Million
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $2,898 - $3,792	40 Added 0.04%	89,240 $8.37 Million
Q4 2021 Feb 14, 2022	BUY	$79.65 - $106.22 $716,850 - $955,980	9,000 Added 11.22%	89,200 $7.6 Million
Q4 2020 Feb 09, 2021	BUY	$86.91 - $108.33 $191,202 - $238,326	2,200 Added 2.82%	80,200 $7.69 Million
Q2 2020 Aug 10, 2020	BUY	$85.09 - $130.36 $340,360 - $521,440	4,000 Added 5.41%	78,000 $9.52 Million
Q1 2020 May 12, 2020	BUY	$75.11 - $113.76 $1.43 Million - $2.16 Million	19,000 Added 34.55%	74,000 $6.41 Million
Q4 2018 Feb 06, 2019	BUY	$68.32 - $124.36 $478,239 - $870,520	7,000 Added 14.58%	55,000 $3.93 Million
Q3 2018 Nov 01, 2018	SELL	$98.88 - $125.85 $197,760 - $251,700	-2,000 Reduced 4.0%	48,000 $5.9 Million
Q2 2018 Aug 02, 2018	SELL	$75.3 - $105.99 $180,720 - $254,376	-2,400 Reduced 4.58%	50,000 $4.91 Million
Q3 2017 Nov 02, 2017	BUY	$47.97 - $61.28 $2.51 Million - $3.21 Million	52,400	52,400 $3.21 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Account

Birchview Capital, LP Neurocrine Biosciences Inc Transaction History